Wedge Capital Management L L P Protagonist Therapeutics, Inc Transaction History

Wedge Capital Management L L P

  • $5.71 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 01, 2019
SELL
$8.98 - $12.96 $1.22 Million - $1.76 Million
-135,594 Closed
0 $0
Q1 2019

May 02, 2019
SELL
$6.5 - $13.77 $339,670 - $719,578
-52,257 Reduced 27.82%
135,594 $1.7 Million
Q3 2018

Nov 01, 2018
BUY
$6.82 - $11.26 $1.28 Million - $2.12 Million
187,851 New
187,851 $1.93 Million

Others Institutions Holding PTGX

# of Institutions
248
Shares Held
56.7M
Call Options Held
76.3K
Put Options Held
114K
View Full List

About Protagonist Therapeutics, Inc

PTGX Quotes by TradingView
  • Ticker PTGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,084,100
  • Market Cap $1.94B
  • Description
  • Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...
More about PTGX
Track This Portfolio

Track Wedge Capital Management L L P Portfolio

Follow Wedge Capital Management L L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedge Capital Management L L P, based on Form 13F filings with the SEC.

News

Stay updated on Wedge Capital Management L L P with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email